|1.||Zhou, Hao: 2 articles (01/2014 - 06/2002)|
|2.||Wu, Yong-Gui: 2 articles (07/2013 - 05/2007)|
|3.||Fu, Guo-sheng: 2 articles (12/2010 - 08/2009)|
|4.||Wang, Min: 2 articles (12/2010 - 08/2009)|
|5.||Zhang, Wen-bin: 2 articles (12/2010 - 08/2009)|
|6.||Zhu, Jun-hui: 2 articles (12/2010 - 08/2009)|
|7.||Zhou, Bin-quan: 2 articles (12/2010 - 08/2009)|
|8.||Song, Yan: 2 articles (12/2007 - 05/2006)|
|9.||Chen, Shi: 2 articles (12/2007 - 05/2006)|
|10.||Zheng, Xiao-Xiang: 2 articles (06/2007 - 11/2004)|
01/01/2008 - "To assess whether dengzhanhua preparations are effective and safe at improving outcomes in patients with acute cerebral infarction. "
06/28/2002 - "Dengzhanhua injection in the treatment of acute cerebral infarction is safe and effective."
01/01/2008 - "Many controlled trials have been undertaken to investigate the efficacy of dengzhanhua preparations in the treatment of acute cerebral infarction. "
06/01/2014 - "To study the clinical effect of Dengzhanhua injection and Xiongqin injection combined with Xuesaitong to treat the elderly patients with acute cerebral infarction. "
01/01/2008 - "Randomised and quasi-randomised controlled clinical trials of dengzhanhua preparations regardless of duration, dosage and route of administration in patients with confirmed acute cerebral infarction. "
01/01/2014 - "The present study was designed to investigate the therapeutic time window and underlying therapeutic mechanism of breviscapine injection against cerebral ischemic/reperfusion injury. "
09/01/2015 - "Cardioprotective effect of breviscapine: inhibition of apoptosis in H9c2 cardiomyocytes via the PI3K/Akt/eNOS pathway following simulated ischemia/reperfusion injury."
12/01/2008 - "Breviscapine, a traditional Chinese medicine, alleviates myocardial ischaemia reperfusion injury in diabetic rats."
01/01/2014 - "The therapeutic time window of breviscapine injection for cerebral ischemia/reperfusion injury seemed to be within 5h after reperfusion. "
01/01/2014 - "Therapeutic time window and underlying therapeutic mechanism of breviscapine injection against cerebral ischemia/reperfusion injury in rats."
|3.||Brain Death (Brain Dead)
12/01/2007 - "Fifteen BA-Ma mini pigs were equally divided into 3 groups at random: brain-dead (group B), breviscapine pretreated (group P), and control (group C). "
05/16/2006 - "Fifteen Ba-ma minipigs were randomly divided into 3 equal groups: brain death group (Group B) made into BD models by increasing the intracranial pressure; breviscapine pretreatment group (Group P), with breviscapine 2.5 mg x kg(-1) given intravenous drip 1-2 hours after the successful establishment of BD model; and control group (Group C) undergoing operation similar to that in Group B but without increasing the intracranial pressure. "
12/01/2007 - "This study was undertaken to investigate liver injury after brain-death in BA-Ma mini pigs and the protective effects of breviscapine on hepatic function and on PKC-alpha mRNA and its protein expression. "
12/01/2007 - "Breviscapine inhibits the degree of PKC-alpha mRNA transcription and its protein translation, decreases the release of inflammatory factors, and thus alleviates hepatic injury during brain-death."
12/01/2007 - "Breviscapine alleviates hepatic injury and inhibits PKC-mRNA and its protein expression in brain-dead BA-Ma mini pigs."
|4.||Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
09/01/2006 - "Protective effects of breviscapine on ischemic vascular dementia in rats."
09/01/2006 - "In this study, we demonstrated the effects of breviscapine on vascular dementia (VD) rats, which were mimicked by permanent occlusion of bilateral common carotid arteries. "
09/01/2006 - "The results suggest that breviscapine has therapeutic effect on cerebral ischemia and vascular dementia."
|5.||Peripheral Nervous System Diseases (PNS Diseases)
01/01/2015 - "Combined therapy of diabetic peripheral neuropathy with breviscapine and mecobalamin: a systematic review and a meta-analysis of Chinese studies."
01/01/2015 - "A meta-analysis on combined therapy of diabetic peripheral neuropathy (DPN) with breviscapine and mecobalamin was performed to evaluate the efficacy of this therapy. "
|2.||Messenger RNA (mRNA)
|8.||Adenosine Triphosphatases (ATPase)
|9.||NF-kappa B (NF-kB)
|1.||Chinese Traditional Medicine (Traditional Chinese Medicine)
|3.||Transplantation (Transplant Recipients)